Overview

Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery

Status:
Unknown status

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate the efficacy of erythropoietin for prevention acute kidney injury in CKD patients undergoing cardiac surgery.

Phase:

Phase 3

Details

Lead Sponsor:

Thammasat University

Treatments:

Epoetin Alfa